Giuseppe Costante

Service(s) : Médecine interne , Endocrinologie

giuseppe.costante [at] hubruxelles.be

Publications

Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy.

Auteurs : Jungels C, Pita JM, Costante G
Année : 2023
Journal : Curr Opin Oncol

Multikinase inhibitors for the treatment of radioiodine refractory thyroid cancer: what have we learned from the 'real-world' experience?

Auteurs : Costante G
Année : 2021
Journal : Curr Opin Oncol

Calcitonin as a biomarker of C cell disease: recent achievements and current challenges.

Auteurs : Costante G, Meringolo D
Année : 2020
Journal : Endocrine

Novel therapeutic options for radioiodine-refractory thyroid cancer: redifferentiation and beyond.

Auteurs : Bulotta S, Celano M, Costante G, Russo D
Année : 2020
Journal : Curr Opin Oncol

Calcitonin and Carcinoembryonic Antigen for the Diagnosis and Management of Medullary Thyroid Carcinoma. in : Luca Giovanella, Editor. Atlas of Thyroid and Neuroendocrine Tumor Markers. Springer

Auteurs : Costante G, Lalami Y, Jungels C, Awada A
Année : 2018
Journal : Book

Plus de publications »